Literature DB >> 2150048

Expression of dopamine D2 receptor and choline acetyltransferase mRNA in the dopamine deafferented rat caudate-putamen.

S Brené1, N Lindefors, M Herrera-Marschitz, H Persson.   

Abstract

In situ hybridization was used to study dopamine D2 receptor (D2R) and choline acetyltransferase (ChAT) mRNA expression in neurons of the rat forebrain, both on control animals and after a unilateral 6-hydroxydopamine (6-OHDA) lesion of midbrain dopamine neurons. D2R mRNA expressing neurons were seen in regions which are known to be heavily innervated by midbrain dopamine fibers such as caudate-putamen, nucleus accumbens and olfactory tubercle. ChAT mRNA expressing neurons were seen in caudate-putamen, nucleus accumbens and septal regions including vertical limb of the diagonal band. In caudate-putamen, approximately 55% of the medium sized neurons, which is the predominating neuronal cell-size in this region, were specifically labeled with the D2R probe. In addition, approximately 95% of the large size neurons in caudate-putamen were specifically labeled with both the D2R and ChAT probes, suggesting that most cholinergic neurons in the caudate-putamen express D2R mRNA. After a unilateral lesion of midbrain dopamine neurons, no change in the level of either D2R or ChAT mRNA were seen in the large size intrinsic cholinergic neurons in caudate-putamen. Similarly, no evidence was obtained for altered levels of D2R mRNA in medium size neurons in medial caudate-putamen, or nucleus accumbens. However, an increase in the number of medium size neurons expressing D2R mRNA was observed in the lateral part of the dopamine deafferented caudate-putamen. Thus, it appears that midbrain dopamine deafferentation causes an increase in D2R mRNA expression in a subpopulation of medium size neurons in the lateral caudate-putamen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2150048     DOI: 10.1007/bf00232197

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  53 in total

1.  Immunohistochemical localization of choline acetyltransferase containing neostriatal neurons and their relationship with dopaminergic synapses.

Authors:  T Hattori; V K Singh; E G McGeer; P L McGeer
Journal:  Brain Res       Date:  1976-01-30       Impact factor: 3.252

2.  Distribution of D2 dopamine receptor mRNA in rat brain.

Authors:  J H Meador-Woodruff; A Mansour; J R Bunzow; H H Van Tol; S J Watson; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Neurokinin A and substance P in striato-nigral neurons in rat brain.

Authors:  N Lindefors; E Brodin; U Ungerstedt
Journal:  Neuropeptides       Date:  1986 Aug-Sep       Impact factor: 3.286

4.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms.

Authors:  B Giros; P Sokoloff; M P Martres; J F Riou; L J Emorine; J C Schwartz
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

5.  Complete sequence of a cDNA encoding an active rat choline acetyltransferase: a tool to investigate the plasticity of cholinergic phenotype expression.

Authors:  A Brice; S Berrard; B Raynaud; S Ansieau; T Coppola; M J Weber; J Mallet
Journal:  J Neurosci Res       Date:  1989-07       Impact factor: 4.164

6.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

7.  Neostriatal choline acetylase and cholinesterase following selective brain lesions.

Authors:  P L McGeer; E G McGeer; H C Fibiger; V Wickson
Journal:  Brain Res       Date:  1971-12-10       Impact factor: 3.252

8.  Cloning and expression of a rat D2 dopamine receptor cDNA.

Authors:  J R Bunzow; H H Van Tol; D K Grandy; P Albert; J Salon; M Christie; C A Machida; K A Neve; O Civelli
Journal:  Nature       Date:  1988 Dec 22-29       Impact factor: 49.962

9.  Evidence for the existence of substance P-containing fibres in striato-nigral and pallido-nigral pathways in rat brain.

Authors:  I Kanazawa; P C Emson; A C Cuello
Journal:  Brain Res       Date:  1977-01-07       Impact factor: 3.252

10.  Coexistence of somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivity in some forebrain neurons.

Authors:  S R Vincent; L Skirboll; T Hökfelt; O Johansson; J M Lundberg; R P Elde; L Terenius; J Kimmel
Journal:  Neuroscience       Date:  1982-02       Impact factor: 3.590

View more
  6 in total

Review 1.  Control of receptor sensitivity at the mRNA level.

Authors:  B J Morris
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

2.  Impaired Acquisition of Nicotine-Induced Conditioned Place Preference in Fatty Acid-Binding Protein 3 Null Mice.

Authors:  Wenbin Jia; Gofarana Wilar; Ichiro Kawahata; An Cheng; Kohji Fukunaga
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

3.  Neurocircuitry of the basal ganglia studied by monitoring neurotransmitter release. Effects of intracerebral and perinatal asphyctic lesions.

Authors:  M Herrera-Marschitz; C F Loidl; Z B You; K Andersson; R Silveira; W T O'Connor; M Goiny
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

4.  Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: II. Effects on extracellular monoamine, acetylcholine and adenosine levels monitored with in vivo microdialysis.

Authors:  M Herrera-Marschitz; J Luthman; S Ferré
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

5.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

6.  Optogenetic self-stimulation in the nucleus accumbens: D1 reward versus D2 ambivalence.

Authors:  Shannon L Cole; Mike J F Robinson; Kent C Berridge
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.